aluates Reports

$ 0.0

Automative

Global Oncology Medication Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-18A5828

Global Oncology Medication Market Insights Forecast to 2028

BUY CHAPTERS

Global Oncology Medication Market Research Report 2025

Code: QYRE-Auto-18A5828

Report

July 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Celgene

Novartis

Bristol–Myers Squibb

Johnson & Johnson

Merck

Astrazeneca plc

Pfizer Inc

Amgen Inc

Takeda

Astellas

Ipsen S A

Sanofi

Bayer

Biogen Idec

Oncology Medication Market Size

The global market for Oncology Medication was valued at US$ 231130 million in the year 2024 and is projected to reach a revised size of US$ 393180 million by 2031, growing at a CAGR of 8.0% during the forecast period.

Oncology Medication Market

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.

Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oncology Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Medication.

The Oncology Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oncology Medication Market Report

Report Metric	Details
Report Name	Oncology Medication Market
Accounted market size in year	US$ 231130 million
Forecasted market size in 2031	US$ 393180 million
CAGR	8.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Chemotherapy Medication Targeted Therapy Medication Immunotherapy Medication Hormonal Therapy Medication Others
Segment by Application	Blood Cancer Breast Cancer Gastrointestinal Cancer Prostate Cancer Respiratory or Lung Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oncology Medication Market growing?

Ans: The Oncology Medication Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the Oncology Medication Market size in 2031?

Ans: The Oncology Medication Market size in 2031 will be US$ 393180 million.

Who are the main players in the Oncology Medication Market report?

Ans: The main players in the Oncology Medication Market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec

What are the Application segmentation covered in the Oncology Medication Market report?

Ans: The Applications covered in the Oncology Medication Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory or Lung Cancer, Others

What are the Type segmentation covered in the Oncology Medication Market report?

Ans: The Types covered in the Oncology Medication Market report are Chemotherapy Medication, Targeted Therapy Medication, Immunotherapy Medication, Hormonal Therapy Medication, Others

Recommended Reports

Cancer Drug Markets

Organ-Specific Oncology

Cancer Diagnostics & Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncology Medication Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Chemotherapy Medication

1.2.3 Targeted Therapy Medication

1.2.4 Immunotherapy Medication

1.2.5 Hormonal Therapy Medication

1.2.6 Others

1.3 Market by Application

1.3.1 Global Oncology Medication Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Blood Cancer

1.3.3 Breast Cancer

1.3.4 Gastrointestinal Cancer

1.3.5 Prostate Cancer

1.3.6 Respiratory or Lung Cancer

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncology Medication Market Perspective (2020-2031)

2.2 Global Oncology Medication Growth Trends by Region

2.2.1 Global Oncology Medication Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oncology Medication Historic Market Size by Region (2020-2025)

2.2.3 Oncology Medication Forecasted Market Size by Region (2026-2031)

2.3 Oncology Medication Market Dynamics

2.3.1 Oncology Medication Industry Trends

2.3.2 Oncology Medication Market Drivers

2.3.3 Oncology Medication Market Challenges

2.3.4 Oncology Medication Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncology Medication Players by Revenue

3.1.1 Global Top Oncology Medication Players by Revenue (2020-2025)

3.1.2 Global Oncology Medication Revenue Market Share by Players (2020-2025)

3.2 Global Oncology Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oncology Medication Revenue

3.4 Global Oncology Medication Market Concentration Ratio

3.4.1 Global Oncology Medication Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncology Medication Revenue in 2024

3.5 Global Key Players of Oncology Medication Head office and Area Served

3.6 Global Key Players of Oncology Medication, Product and Application

3.7 Global Key Players of Oncology Medication, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Medication Breakdown Data by Type

4.1 Global Oncology Medication Historic Market Size by Type (2020-2025)

4.2 Global Oncology Medication Forecasted Market Size by Type (2026-2031)

5 Oncology Medication Breakdown Data by Application

5.1 Global Oncology Medication Historic Market Size by Application (2020-2025)

5.2 Global Oncology Medication Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oncology Medication Market Size (2020-2031)

6.2 North America Oncology Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oncology Medication Market Size by Country (2020-2025)

6.4 North America Oncology Medication Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncology Medication Market Size (2020-2031)

7.2 Europe Oncology Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oncology Medication Market Size by Country (2020-2025)

7.4 Europe Oncology Medication Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oncology Medication Market Size (2020-2031)

8.2 Asia-Pacific Oncology Medication Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oncology Medication Market Size by Region (2020-2025)

8.4 Asia-Pacific Oncology Medication Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oncology Medication Market Size (2020-2031)

9.2 Latin America Oncology Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oncology Medication Market Size by Country (2020-2025)

9.4 Latin America Oncology Medication Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncology Medication Market Size (2020-2031)

10.2 Middle East & Africa Oncology Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oncology Medication Market Size by Country (2020-2025)

10.4 Middle East & Africa Oncology Medication Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Oncology Medication Introduction

11.1.4 Roche Revenue in Oncology Medication Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Celgene

11.2.1 Celgene Company Details

11.2.2 Celgene Business Overview

11.2.3 Celgene Oncology Medication Introduction

11.2.4 Celgene Revenue in Oncology Medication Business (2020-2025)

11.2.5 Celgene Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Oncology Medication Introduction

11.3.4 Novartis Revenue in Oncology Medication Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Details

11.4.2 Bristol-Myers Squibb Business Overview

11.4.3 Bristol-Myers Squibb Oncology Medication Introduction

11.4.4 Bristol-Myers Squibb Revenue in Oncology Medication Business (2020-2025)

11.4.5 Bristol-Myers Squibb Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Oncology Medication Introduction

11.5.4 Johnson & Johnson Revenue in Oncology Medication Business (2020-2025)

11.5.5 Johnson & Johnson Recent Development

11.6 Merck & Co.

11.6.1 Merck & Co. Company Details

11.6.2 Merck & Co. Business Overview

11.6.3 Merck & Co. Oncology Medication Introduction

11.6.4 Merck & Co. Revenue in Oncology Medication Business (2020-2025)

11.6.5 Merck & Co. Recent Development

11.7 AstraZeneca

11.7.1 AstraZeneca Company Details

11.7.2 AstraZeneca Business Overview

11.7.3 AstraZeneca Oncology Medication Introduction

11.7.4 AstraZeneca Revenue in Oncology Medication Business (2020-2025)

11.7.5 AstraZeneca Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Oncology Medication Introduction

11.8.4 Pfizer Revenue in Oncology Medication Business (2020-2025)

11.8.5 Pfizer Recent Development

11.9 Amgen

11.9.1 Amgen Company Details

11.9.2 Amgen Business Overview

11.9.3 Amgen Oncology Medication Introduction

11.9.4 Amgen Revenue in Oncology Medication Business (2020-2025)

11.9.5 Amgen Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Oncology Medication Introduction

11.10.4 Takeda Revenue in Oncology Medication Business (2020-2025)

11.10.5 Takeda Recent Development

11.11 Astellas

11.11.1 Astellas Company Details

11.11.2 Astellas Business Overview

11.11.3 Astellas Oncology Medication Introduction

11.11.4 Astellas Revenue in Oncology Medication Business (2020-2025)

11.11.5 Astellas Recent Development

11.12 Ipsen

11.12.1 Ipsen Company Details

11.12.2 Ipsen Business Overview

11.12.3 Ipsen Oncology Medication Introduction

11.12.4 Ipsen Revenue in Oncology Medication Business (2020-2025)

11.12.5 Ipsen Recent Development

11.13 Sanofi

11.13.1 Sanofi Company Details

11.13.2 Sanofi Business Overview

11.13.3 Sanofi Oncology Medication Introduction

11.13.4 Sanofi Revenue in Oncology Medication Business (2020-2025)

11.13.5 Sanofi Recent Development

11.14 Bayer

11.14.1 Bayer Company Details

11.14.2 Bayer Business Overview

11.14.3 Bayer Oncology Medication Introduction

11.14.4 Bayer Revenue in Oncology Medication Business (2020-2025)

11.14.5 Bayer Recent Development

11.15 Biogen Idec

11.15.1 Biogen Idec Company Details

11.15.2 Biogen Idec Business Overview

11.15.3 Biogen Idec Oncology Medication Introduction

11.15.4 Biogen Idec Revenue in Oncology Medication Business (2020-2025)

11.15.5 Biogen Idec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Celgene

Novartis

Bristol–Myers Squibb

Johnson & Johnson

Merck

Astrazeneca plc

Pfizer Inc

Amgen Inc

Takeda

Astellas

Ipsen S A

Sanofi

Bayer

Biogen Idec

List of Tables

Table 1. Global Oncology Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Chemotherapy Medication

Table 3. Key Players of Targeted Therapy Medication

Table 4. Key Players of Immunotherapy Medication

Table 5. Key Players of Hormonal Therapy Medication

Table 6. Key Players of Others

Table 7. Global Oncology Medication Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Oncology Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Oncology Medication Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Oncology Medication Market Share by Region (2020-2025)

Table 11. Global Oncology Medication Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Oncology Medication Market Share by Region (2026-2031)

Table 13. Oncology Medication Market Trends

Table 14. Oncology Medication Market Drivers

Table 15. Oncology Medication Market Challenges

Table 16. Oncology Medication Market Restraints

Table 17. Global Oncology Medication Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Oncology Medication Market Share by Players (2020-2025)

Table 19. Global Top Oncology Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Medication as of 2024)

Table 20. Ranking of Global Top Oncology Medication Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Oncology Medication Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Oncology Medication, Headquarters and Area Served

Table 23. Global Key Players of Oncology Medication, Product and Application

Table 24. Global Key Players of Oncology Medication, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Oncology Medication Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Oncology Medication Revenue Market Share by Type (2020-2025)

Table 28. Global Oncology Medication Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Oncology Medication Revenue Market Share by Type (2026-2031)

Table 30. Global Oncology Medication Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Oncology Medication Revenue Market Share by Application (2020-2025)

Table 32. Global Oncology Medication Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Oncology Medication Revenue Market Share by Application (2026-2031)

Table 34. North America Oncology Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Oncology Medication Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Oncology Medication Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Oncology Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Oncology Medication Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Oncology Medication Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Oncology Medication Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Oncology Medication Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Oncology Medication Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Oncology Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Oncology Medication Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Oncology Medication Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Oncology Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Oncology Medication Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Oncology Medication Market Size by Country (2026-2031) & (US$ Million)

Table 49. Roche Company Details

Table 50. Roche Business Overview

Table 51. Roche Oncology Medication Product

Table 52. Roche Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 53. Roche Recent Development

Table 54. Celgene Company Details

Table 55. Celgene Business Overview

Table 56. Celgene Oncology Medication Product

Table 57. Celgene Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 58. Celgene Recent Development

Table 59. Novartis Company Details

Table 60. Novartis Business Overview

Table 61. Novartis Oncology Medication Product

Table 62. Novartis Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 63. Novartis Recent Development

Table 64. Bristol-Myers Squibb Company Details

Table 65. Bristol-Myers Squibb Business Overview

Table 66. Bristol-Myers Squibb Oncology Medication Product

Table 67. Bristol-Myers Squibb Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 68. Bristol-Myers Squibb Recent Development

Table 69. Johnson & Johnson Company Details

Table 70. Johnson & Johnson Business Overview

Table 71. Johnson & Johnson Oncology Medication Product

Table 72. Johnson & Johnson Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 73. Johnson & Johnson Recent Development

Table 74. Merck & Co. Company Details

Table 75. Merck & Co. Business Overview

Table 76. Merck & Co. Oncology Medication Product

Table 77. Merck & Co. Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 78. Merck & Co. Recent Development

Table 79. AstraZeneca Company Details

Table 80. AstraZeneca Business Overview

Table 81. AstraZeneca Oncology Medication Product

Table 82. AstraZeneca Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 83. AstraZeneca Recent Development

Table 84. Pfizer Company Details

Table 85. Pfizer Business Overview

Table 86. Pfizer Oncology Medication Product

Table 87. Pfizer Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 88. Pfizer Recent Development

Table 89. Amgen Company Details

Table 90. Amgen Business Overview

Table 91. Amgen Oncology Medication Product

Table 92. Amgen Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 93. Amgen Recent Development

Table 94. Takeda Company Details

Table 95. Takeda Business Overview

Table 96. Takeda Oncology Medication Product

Table 97. Takeda Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 98. Takeda Recent Development

Table 99. Astellas Company Details

Table 100. Astellas Business Overview

Table 101. Astellas Oncology Medication Product

Table 102. Astellas Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 103. Astellas Recent Development

Table 104. Ipsen Company Details

Table 105. Ipsen Business Overview

Table 106. Ipsen Oncology Medication Product

Table 107. Ipsen Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 108. Ipsen Recent Development

Table 109. Sanofi Company Details

Table 110. Sanofi Business Overview

Table 111. Sanofi Oncology Medication Product

Table 112. Sanofi Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 113. Sanofi Recent Development

Table 114. Bayer Company Details

Table 115. Bayer Business Overview

Table 116. Bayer Oncology Medication Product

Table 117. Bayer Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 118. Bayer Recent Development

Table 119. Biogen Idec Company Details

Table 120. Biogen Idec Business Overview

Table 121. Biogen Idec Oncology Medication Product

Table 122. Biogen Idec Revenue in Oncology Medication Business (2020-2025) & (US$ Million)

Table 123. Biogen Idec Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

Table 127. Authors List of This Report

List of Figures

Figure 1. Oncology Medication Picture

Figure 2. Global Oncology Medication Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oncology Medication Market Share by Type: 2024 VS 2031

Figure 4. Chemotherapy Medication Features

Figure 5. Targeted Therapy Medication Features

Figure 6. Immunotherapy Medication Features

Figure 7. Hormonal Therapy Medication Features

Figure 8. Others Features

Figure 9. Global Oncology Medication Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Oncology Medication Market Share by Application: 2024 VS 2031

Figure 11. Blood Cancer Case Studies

Figure 12. Breast Cancer Case Studies

Figure 13. Gastrointestinal Cancer Case Studies

Figure 14. Prostate Cancer Case Studies

Figure 15. Respiratory or Lung Cancer Case Studies

Figure 16. Others Case Studies

Figure 17. Oncology Medication Report Years Considered

Figure 18. Global Oncology Medication Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Oncology Medication Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Oncology Medication Market Share by Region: 2024 VS 2031

Figure 21. Global Oncology Medication Market Share by Players in 2024

Figure 22. Global Top Oncology Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Medication as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Oncology Medication Revenue in 2024

Figure 24. North America Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Oncology Medication Market Share by Country (2020-2031)

Figure 26. United States Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Oncology Medication Market Share by Country (2020-2031)

Figure 30. Germany Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Oncology Medication Market Share by Region (2020-2031)

Figure 38. China Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Oncology Medication Market Share by Country (2020-2031)

Figure 46. Mexico Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Oncology Medication Market Share by Country (2020-2031)

Figure 50. Turkey Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Oncology Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Roche Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 54. Celgene Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 57. Johnson & Johnson Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 58. Merck & Co. Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 59. AstraZeneca Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 60. Pfizer Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 61. Amgen Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 62. Takeda Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 63. Astellas Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 64. Ipsen Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 65. Sanofi Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 66. Bayer Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 67. Biogen Idec Revenue Growth Rate in Oncology Medication Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oncology Drugs Market Insights Forecast to 2030

Global Drugs for Oncology Market Insights Forecast to 2030

Global Oncology Therapeutic Drug Market Research Report 2024

Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Separation and Characterization in Solid Tumors Market Insights Forecast to 2030

Global Solid Tumor Therapeutics Market Research Report 2024

Global Brain Cancer Targeted Drug Market Research Report 2025

Global Brain Tumor Therapeutics Market Research Report 2024

Global Targeted Therapy for Brain Cancer Market Research Report 2025

Global Oncology Small Molecule Drugs Market Insights Forecast to 2030

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Breast Cancer Targeted Drug Market Research Report 2025

Global Brain and Central Nervous System Cancer Treatments Market Research Report 2024

Global Tumor Genomics Market Research Report 2024

Global Rectal Cancer Therapeutics Market Insights Forecast to 2030

Global Bone Tumor Ablation Devices Market Research Report 2024

Global Oncology EMR Software Market Insights Forecast to 2030

Musculoskeletal Tumor Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Therapy for Breast Cancer Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions